`
`2024-1061
`Allergan USA, Inc. v. MSN Laboratories Private Ltd.
`Sun Pharmaceutical Industries Limited
`
`USDC, Delaware
`
`1:19-cv-01727-RGA
`
`Patent Infringement
`
`Affirmation of the district court's judgment for Sun.
`
`Final judgment in favor of Sun as to all infringement claims and Sun's counterclaims for
`invalidity of U.S. Patent Nos. 11,007,179, 11,090,291, 11,160,792, 11,311,516, and 7,741,356.
`
`After a three day bench trial, the district court found that U.S. Patent Nos. 11,007,179, 11,090,291, 11,160,792,
`11,311,516, are invalid for lack of written description and 7,741,356 is invalid for obviousness-type double patenting
`and further dismissed Plaintiffs' claims of patent infringement.
`
`10/12/23
`
`
`
`Case: 24-1061 Document: 8 Page: 2 Filed: 11/02/2023
`
`Whether the district court's decision on invalidity and infringement should be affirmed.
`
`The parties have already engaged in settlement discussions which were
`unsuccessful.
`
`11/2/23
`
`/s/ Charles B. Klein
`Charles B. Klein
`
`